CANAAN X L.P.

Insider Buys Quantity –
4
2019-05-28PurchaseIDEAYA Biosciences, Inc.
IDYA
10 percent owner
800,000
8.5467%
$10.00$8M-37.23%
2019-05-13PurchaseNextCure, Inc.
NXTC
10 percent owner
50,000
0.2864%
$15.00$750,000+82.16%
2018-05-30PurchaseIterum Therapeutics plc
ITRM
1.01M
15.3014%
$13.00$13.17M-40.58%
2018-05-17SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
77,936
0.3737%
$6.09$474,716+36.06%
2018-05-16SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
58,882
0.2779%
$6.46$380,142+26.05%
2018-05-15SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
115,430
0.547%
$6.48$748,160+25.58%
2018-05-14SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
155,182
0.726%
$6.37$988,447+26.01%
2018-03-23SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
59,950
0.2878%
$20.71$1.24M-60.5%
2018-03-22SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
9,518
0.0471%
$20.62$196,266-59.1%
2018-03-21SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
35,398
0.1693%
$20.61$729,454-60.46%
2018-03-20SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
34,120
0.1619%
$20.61$703,077-60.77%
2018-03-19SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
26,878
0.1271%
$20.57$552,891-60.84%
2018-03-16SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
13,852
0.0663%
$20.51$284,125-60.25%
2018-03-15SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
23,502
0.1116%
$20.64$485,041-60.81%
2018-03-14SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
400
0.0019%
$20.77$8,308-60.46%
2018-03-13SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
2,408
0.0115%
$20.84$50,188-60.96%
2016-08-16PurchaseProtagonist Therapeutics, Inc.
PTGX
583,333
7.2004%
$12.00$7M+18.24%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us